Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.02
INFU's Cash to Debt is ranked lower than
98% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.70 vs. INFU: 0.02 )
Ranked among companies with meaningful Cash to Debt only.
INFU' s Cash to Debt Range Over the Past 10 Years
Min: 0.02  Med: 0.12 Max: No Debt
Current: 0.02
Equity to Asset 0.53
INFU's Equity to Asset is ranked lower than
63% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.61 vs. INFU: 0.53 )
Ranked among companies with meaningful Equity to Asset only.
INFU' s Equity to Asset Range Over the Past 10 Years
Min: 0.52  Med: 0.58 Max: 0.71
Current: 0.53
0.52
0.71
Interest Coverage 5.20
INFU's Interest Coverage is ranked lower than
71% of the 122 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.00 vs. INFU: 5.20 )
Ranked among companies with meaningful Interest Coverage only.
INFU' s Interest Coverage Range Over the Past 10 Years
Min: 0.6  Med: 1.61 Max: 5.2
Current: 5.2
0.6
5.2
F-Score: 6
Z-Score: 1.56
M-Score: -2.31
WACC vs ROIC
2.42%
7.29%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 12.29
INFU's Operating margin (%) is ranked higher than
69% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.20 vs. INFU: 12.29 )
Ranked among companies with meaningful Operating margin (%) only.
INFU' s Operating margin (%) Range Over the Past 10 Years
Min: -121.45  Med: 9.47 Max: 14.03
Current: 12.29
-121.45
14.03
Net-margin (%) 5.19
INFU's Net-margin (%) is ranked higher than
58% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.71 vs. INFU: 5.19 )
Ranked among companies with meaningful Net-margin (%) only.
INFU' s Net-margin (%) Range Over the Past 10 Years
Min: -83.17  Med: 1.99 Max: 28.12
Current: 5.19
-83.17
28.12
ROE (%) 7.78
INFU's ROE (%) is ranked higher than
58% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.62 vs. INFU: 7.78 )
Ranked among companies with meaningful ROE (%) only.
INFU' s ROE (%) Range Over the Past 10 Years
Min: -72.53  Med: -0.63 Max: 13.38
Current: 7.78
-72.53
13.38
ROA (%) 4.16
INFU's ROA (%) is ranked higher than
62% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.86 vs. INFU: 4.16 )
Ranked among companies with meaningful ROA (%) only.
INFU' s ROA (%) Range Over the Past 10 Years
Min: -43.99  Med: -0.42 Max: 8.56
Current: 4.16
-43.99
8.56
ROC (Joel Greenblatt) (%) 21.20
INFU's ROC (Joel Greenblatt) (%) is ranked higher than
66% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.00 vs. INFU: 21.20 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
INFU' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -319.11  Med: 21.21 Max: 117.01
Current: 21.2
-319.11
117.01
Revenue Growth (3Y)(%) 4.80
INFU's Revenue Growth (3Y)(%) is ranked higher than
50% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. INFU: 4.80 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
INFU' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 5.20 Max: 88.1
Current: 4.8
0
88.1
EBITDA Growth (3Y)(%) 14.90
INFU's EBITDA Growth (3Y)(%) is ranked higher than
70% of the 133 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.90 vs. INFU: 14.90 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
INFU' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -10.2  Med: 13.40 Max: 14.9
Current: 14.9
-10.2
14.9
» INFU's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-05-12)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2015

INFU Guru Trades in Q2 2015

Mario Gabelli 28,980 sh (unchged)
Jim Simons 15,663 sh (-29.45%)
» More
Q3 2015

INFU Guru Trades in Q3 2015

Mario Gabelli 28,980 sh (unchged)
Jim Simons Sold Out
» More
Q4 2015

INFU Guru Trades in Q4 2015

Jim Simons 14,600 sh (New)
Mario Gabelli 28,980 sh (unchged)
» More
Q1 2016

INFU Guru Trades in Q1 2016

Mario Gabelli 28,980 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with INFU

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 20.69
INFU's P/E(ttm) is ranked higher than
65% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.55 vs. INFU: 20.69 )
Ranked among companies with meaningful P/E(ttm) only.
INFU' s P/E(ttm) Range Over the Past 10 Years
Min: 2.73  Med: 27.58 Max: 178
Current: 20.69
2.73
178
PE(NRI) 20.69
INFU's PE(NRI) is ranked higher than
65% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.55 vs. INFU: 20.69 )
Ranked among companies with meaningful PE(NRI) only.
INFU' s PE(NRI) Range Over the Past 10 Years
Min: 2.71  Med: 27.50 Max: 178
Current: 20.69
2.71
178
P/B 1.43
INFU's P/B is ranked higher than
71% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.68 vs. INFU: 1.43 )
Ranked among companies with meaningful P/B only.
INFU' s P/B Range Over the Past 10 Years
Min: 0.33  Med: 0.80 Max: 1.96
Current: 1.43
0.33
1.96
P/S 1.02
INFU's P/S is ranked higher than
71% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.49 vs. INFU: 1.02 )
Ranked among companies with meaningful P/S only.
INFU' s P/S Range Over the Past 10 Years
Min: 0.36  Med: 0.97 Max: 6.21
Current: 1.02
0.36
6.21
POCF 10.76
INFU's POCF is ranked higher than
73% of the 100 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.04 vs. INFU: 10.76 )
Ranked among companies with meaningful POCF only.
INFU' s POCF Range Over the Past 10 Years
Min: 2.39  Med: 6.02 Max: 12.87
Current: 10.76
2.39
12.87
EV-to-EBIT 15.65
INFU's EV-to-EBIT is ranked higher than
66% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.75 vs. INFU: 15.65 )
Ranked among companies with meaningful EV-to-EBIT only.
INFU' s EV-to-EBIT Range Over the Past 10 Years
Min: -114.9  Med: 11.70 Max: 664.8
Current: 15.65
-114.9
664.8
EV-to-EBITDA 11.22
INFU's EV-to-EBITDA is ranked higher than
71% of the 133 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.31 vs. INFU: 11.22 )
Ranked among companies with meaningful EV-to-EBITDA only.
INFU' s EV-to-EBITDA Range Over the Past 10 Years
Min: -3.9  Med: 7.80 Max: 19.4
Current: 11.22
-3.9
19.4
Current Ratio 1.34
INFU's Current Ratio is ranked lower than
83% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.64 vs. INFU: 1.34 )
Ranked among companies with meaningful Current Ratio only.
INFU' s Current Ratio Range Over the Past 10 Years
Min: 0.08  Med: 1.23 Max: 6.46
Current: 1.34
0.08
6.46
Quick Ratio 1.22
INFU's Quick Ratio is ranked lower than
68% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.70 vs. INFU: 1.22 )
Ranked among companies with meaningful Quick Ratio only.
INFU' s Quick Ratio Range Over the Past 10 Years
Min: 0.08  Med: 1.12 Max: 6.46
Current: 1.22
0.08
6.46
Days Inventory 32.97
INFU's Days Inventory is ranked higher than
95% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 127.92 vs. INFU: 32.97 )
Ranked among companies with meaningful Days Inventory only.
INFU' s Days Inventory Range Over the Past 10 Years
Min: 14.99  Med: 28.54 Max: 41.01
Current: 32.97
14.99
41.01
Days Sales Outstanding 71.89
INFU's Days Sales Outstanding is ranked lower than
60% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.57 vs. INFU: 71.89 )
Ranked among companies with meaningful Days Sales Outstanding only.
INFU' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.96  Med: 52.81 Max: 349.58
Current: 71.89
42.96
349.58
Days Payable 114.79
INFU's Days Payable is ranked higher than
78% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 55.85 vs. INFU: 114.79 )
Ranked among companies with meaningful Days Payable only.
INFU' s Days Payable Range Over the Past 10 Years
Min: 40.19  Med: 75.79 Max: 242.43
Current: 114.79
40.19
242.43

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 3.76
INFU's Price/Tangible Book is ranked higher than
50% of the 167 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.11 vs. INFU: 3.76 )
Ranked among companies with meaningful Price/Tangible Book only.
INFU' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.6  Med: 2.71 Max: 3.45
Current: 3.76
1.6
3.45
Price/Projected FCF 1.77
INFU's Price/Projected FCF is ranked higher than
52% of the 89 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.93 vs. INFU: 1.77 )
Ranked among companies with meaningful Price/Projected FCF only.
INFU' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.51  Med: 0.66 Max: 1.61
Current: 1.77
0.51
1.61
Price/Median PS Value 1.07
INFU's Price/Median PS Value is ranked lower than
58% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. INFU: 1.07 )
Ranked among companies with meaningful Price/Median PS Value only.
INFU' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.56  Med: 1.04 Max: 1.24
Current: 1.07
0.56
1.24
Price/Graham Number 1.86
INFU's Price/Graham Number is ranked higher than
58% of the 113 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. INFU: 1.86 )
Ranked among companies with meaningful Price/Graham Number only.
INFU' s Price/Graham Number Range Over the Past 10 Years
Min: 1.68  Med: 1.78 Max: 2.24
Current: 1.86
1.68
2.24
Earnings Yield (Greenblatt) (%) 6.43
INFU's Earnings Yield (Greenblatt) (%) is ranked higher than
79% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. INFU: 6.43 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
INFU' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.2  Med: 7.60 Max: 30.8
Current: 6.43
0.2
30.8

More Statistics

Revenue(Mil) $72
EPS $ 0.16
Beta0.03
Short Percentage of Float1.87%
52-Week Range $2.22 - 3.75
Shares Outstanding(Mil)22.62

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:NAS:HBIOV, TSE:7702, XKRX:104540, HKSE:00899, BSP:CREM3, NAS:SSRG » details
InfuSystems Holdings Inc a Delaware corporation was formed on August 15, 2005. The Company is a provider of infusion pumps and related services in the United States. It provides its services to hospitals, oncology practices and facilities and other alternate site health care providers. The Company delivers local, field-based customer support, and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. Its core service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics to be utilized in the treatment of a variety of cancers including colorectal cancer. The Company provides these pumps and related supplies to oncology clinics, obtain an assignment of insurance benefits from the patient, and bill the patient's insurance company or patient as appropriate, for the use of the pump and supplies, and collect payment. It also provide pump management services for the pumps and associated disposable supply kits to approximately 1,800 oncology clinics in the United States, while retaining title to the pumps during this process. The competition is primarily composed of regional DME providers, hospital-owned DME providers, physician providers and home care infusion providers. The operations comply with applicable federal, state and local environmental laws.
» More Articles for INFU

Headlines

Articles On GuruFocus.com
Meson Capital 2Q Letter Aug 19 2015 
Applying Buffett’s Arbitrage Techniques to Infusystem Jul 31 2013 
InfuSystem Buyout Coming with 32% Upside Potential Jul 22 2013 

More From Other Websites
InfuSystem Holdings, Inc.: Fading performance but may be making a comeback? Apr 20 2016
InfuSystem Agrees to Acquire Infusion Pump Assets from InfusAID, LLC Apr 15 2016
InfuSystem Agrees to Acquire Infusion Pump Assets from InfusAID, LLC Apr 15 2016
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Mar 14 2016
INFUSYSTEM HOLDINGS, INC Financials Mar 12 2016
InfuSystem to Participate in the 28th Annual ROTH Conference on Monday, March 14, 2016 Mar 10 2016
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 09 2016
InfuSystem Holdings, Inc. Reports Fourth Quarter And Year End 2015 Financial Results Mar 09 2016
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 02 2016
InfuSystem To Issue Fourth Quarter And Year End 2015 Financial Results On Wednesday, March 9, 2016 Mar 02 2016
13D Filing: Meridian OHC Partners Gunning for Board Seat at Infusystem Holdings, Inc (INFU) Feb 15 2016
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Feb 02 2016
InfuSystem EXPRESS™ Integrates with the Cerner System at The University of Missouri's Ellis... Jan 22 2016
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jan 21 2016
InfuSystem Holdings, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 17 2015
Capturing Changes in Investor Sentiments - Research on TransAtlantic Petroleum, InfuSystem Holdings,... Dec 04 2015
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 12 2015
InfuSystem Holdings, Inc. Reports Third Quarter 2015 Financial Results Nov 12 2015
InfuSystem Holdings, Inc. Reports Third Quarter 2015 Financial Results Nov 12 2015
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 05 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK